Images
The newspaper “El País” devotes a feature to a recent study on metastatic breast cancer headed by Toni Celià-Terrassa, associate researcher at Princeton University, and includes the opinion of Roger Gomis, ICREA researcher and group leader of the Growth Control and Cancer Metastasis Lab at IRB Barcelona.
Published in Nature Cell Biology, the study identifies the RNA molecule that shields breast cancer stem cells from the immune system.
Roger Gomis stresses that the work contributes "fundamental knowledge", but adds that translating it into possible short-term treatments will be challenging.
Link to El País - Materia
Link to El País, Brasil
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
